TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32762677

Group type: EXPERIMENTAL
Intervention: Integrated EMDR-Dialectical Behavioural Therapy (DBT)
Number of subjects: 126

Group type: COMPARATOR
Intervention: EMDR-only
Number of subjects: 126
Study: 33570304

Group type: EXPERIMENTAL
Intervention: PCC via telephone added to usual care
Number of subjects: 105

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 105
Study: 35841488

Group type: EXPERIMENTAL
Intervention: Machined neck implants
Number of subjects: 58

Group type: COMPARATOR
Intervention: Rough neck implants
Number of subjects: 58
Study: 34313610

Group type: EXPERIMENTAL
Intervention: 80% FiO2
Number of subjects: 100

Group type: COMPARATOR
Intervention: 30% FiO2
Number of subjects: 100
Study: 32248935

Group type: EXPERIMENTAL
Intervention: Mindfulness smartphone-app intervention
Number of subjects: 23
Study: 36111476

Group type: EXPERIMENTAL
Intervention: 3D printed porous titanium alloy cage (3D Cage)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Poly-ether-ether-ketone cage (PEEK Cage)
Number of subjects: 66
Study: 33607327

Group type: EXPERIMENTAL
Intervention: Citalopram
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 32483076

Group type: EXPERIMENTAL
Intervention: C-loop haptic toric IOL (AcrySof Toric IOL, Group A)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Plate-haptic toric IOL (AT TORBI 709M, Group B)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: C-loop haptic toric IOL (Group A)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Plate-haptic toric IOL (Group B)
Number of subjects: 62
Study: 34838153

Group type: EXPERIMENTAL
Intervention: BPM-P (parent version)
Number of subjects: 1346

Group type: EXPERIMENTAL
Intervention: BPM-T (teacher version)
Number of subjects: 1346

Group type: EXPERIMENTAL
Intervention: BPM-P and BPM-T
Number of subjects: 1346

Group type: EXPERIMENTAL
Intervention: BPM-P
Number of subjects: 1346

Group type: EXPERIMENTAL
Intervention: BPM-T
Number of subjects: 1346
Study: 32329771

Group type: EXPERIMENTAL
Intervention: Higher circulating progesterone levels
Number of subjects: 15595

Group type: EXPERIMENTAL
Intervention: Elevated progesterone concentrations among women in the lowest quintile of estradiol (<6.30 pg/mL)
Number of subjects: 15595

Group type: EXPERIMENTAL
Intervention: Elevated progesterone concentrations among women in higher quintiles of estradiol (Q2‐Q5; ≥6.30 pg/mL)
Number of subjects: 15595
Study: 34128486

Group type: EXPERIMENTAL
Intervention: Nicotine-containing e-cigarettes
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Nicotine-free e-cigarettes
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Nicotine Replacement Therapy (NRT)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: E-cigarettes (both types)
Number of subjects: 17
Study: 34030124

Group type: EXPERIMENTAL
Intervention: Heat condition (35 °C)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Carbohydrate and polyunsaturated fat intake 24 hr preexercise
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Protein, carbohydrate, total fat, and polyunsaturated fat intake (8 days)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Thermoneutral condition (21 °C)
Number of subjects: 12
Study: 33966678

Group type: EXPERIMENTAL
Intervention: Lurasidone (40, 80, 120, or 160 mg)
Number of subjects: 537

Group type: EXPERIMENTAL
Intervention: Lurasidone (combined doses)
Number of subjects: 537

Group type: EXPERIMENTAL
Intervention: Lurasidone
Number of subjects: 537

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 537
Study: 32003538

Group type: EXPERIMENTAL
Intervention: Phacoemulsification with iStent implantation (phaco-iStent)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Phacoemulsification alone (phaco)
Number of subjects: 32
Study: 32974732

Group type: EXPERIMENTAL
Intervention: Apararenone 2.5 mg
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: Apararenone 5 mg
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: Apararenone 10 mg
Number of subjects: 219

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: Apararenone (all doses)
Number of subjects: 219
Study: 32912192

Group type: EXPERIMENTAL
Intervention: EHR-integrated decision tool with education for physicians and nursing staff
Number of subjects: 897

Group type: COMPARATOR
Intervention: Care as usual (Control)
Number of subjects: 897
Study: 35615013

Group type: EXPERIMENTAL
Intervention: DEX+MZ+FEN (DMF)
Number of subjects: 0

Group type: COMPARATOR
Intervention: DEX+MZ (DM)
Number of subjects: 0
Study: 32853709

Group type: EXPERIMENTAL
Intervention: 0.1% topical betamethasone valerate cream applied once a day after radiation
Number of subjects: 150

Group type: COMPARATOR
Intervention: Best supportive care
Number of subjects: 150
Study: 34592049

Group type: EXPERIMENTAL
Intervention: Strong opioids
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Counseling about opioid effects
Number of subjects: 300
Study: 33024992

Group type: EXPERIMENTAL
Intervention: Tofacitinib (5 mg twice per day for at least 6 months)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Tofacitinib
Number of subjects: 3
Study: 33202066

Group type: EXPERIMENTAL
Intervention: Cefazolin 2 g
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Cefazolin 1 g
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Cefazolin (1 or 2 g)
Number of subjects: 62
Study: 33046026

Group type: EXPERIMENTAL
Intervention: Combined pain management with skin-to-skin contact, breastfeeding, and live parental lullaby singing
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard pain care initiated by health care professionals
Number of subjects: 0
Study: 35257962

Group type: EXPERIMENTAL
Intervention: Monthly intravitreal 2 mg aflibercept (arm 1)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Quarterly intravitreal 2 mg aflibercept (arm 2)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Both treatment arms
Number of subjects: 27
Study: 32873675

Group type: EXPERIMENTAL
Intervention: Standard care plus person-centred care (PCC) by telephone and a digital platform
Number of subjects: 220

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 220
Study: 33462447

Group type: EXPERIMENTAL
Intervention: High-frequency neuromodulation targeting the orbitofrontal cortex, personalized to the intrinsic beta–gamma frequency of the reward network, applied chronically over 5 days.
Number of subjects: 0
Study: 32755413

Group type: EXPERIMENTAL
Intervention: Low-dose aspirin
Number of subjects: 1228

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1228

Group type: EXPERIMENTAL
Intervention: Preconception blood pressure levels
Number of subjects: 1228

Group type: EXPERIMENTAL
Intervention: Change in blood pressure from preconception to early pregnancy
Number of subjects: 1228
Study: 36163885

Group type: EXPERIMENTAL
Intervention: Venetoclax-Obinutuzumab (Ven-Obi)
Number of subjects: 432

Group type: COMPARATOR
Intervention: Chlorambucil-Obinutuzumab (Clb-Obi)
Number of subjects: 432
Study: 33667465

Group type: EXPERIMENTAL
Intervention: Serum high-density lipoprotein (HDL) cholesterol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Apolipoprotein A1 (ApoA1) levels
Number of subjects: 0

Group type: COMPARATOR
Intervention: ApoE4 alleles
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Genetically higher HDL cholesterol levels
Number of subjects: 0
Study: 32343081

Group type: EXPERIMENTAL
Intervention: 10‐5‐HIIT
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: 20‐10‐HIIT
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 34
Study: 33978334

Group type: EXPERIMENTAL
Intervention: G1 - Spoken feedback with app visibility
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: G2 - Instructor feedback with app visibility only for instructor
Number of subjects: 0

Group type: COMPARATOR
Intervention: G3 - Control group with no app visibility
Number of subjects: 0
Study: 32790699

Group type: EXPERIMENTAL
Intervention: Religious music
Number of subjects: 408

Group type: EXPERIMENTAL
Intervention: Secular music
Number of subjects: 408

Group type: EXPERIMENTAL
Intervention: White noise
Number of subjects: 408

Group type: COMPARATOR
Intervention: No music (control)
Number of subjects: 408
Study: 36324139

Group type: EXPERIMENTAL
Intervention: Methylene blue 0.025% + conventional therapy (CTx)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Methylene blue 0.05% + conventional therapy (CTx)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Methylene blue 0.1% + conventional therapy (CTx)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional therapy (CTx) alone
Number of subjects: 60
Study: 33801019

Group type: EXPERIMENTAL
Intervention: Ascorbic acid supplementation, 745 mg daily for an average of 12.4 years
Number of subjects: 9664

Group type: EXPERIMENTAL
Intervention: Ascorbic acid dietary intake
Number of subjects: 9664

Group type: EXPERIMENTAL
Intervention: Ascorbic acid blood concentration
Number of subjects: 9664
Study: 33095030

Group type: EXPERIMENTAL
Intervention: Inhaled treprostinil
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 32112556

Group type: EXPERIMENTAL
Intervention: Integrated care intervention (quarterly AF check-ups by trained nurses, monitoring of anticoagulation therapy, consultations from cardiologists)
Number of subjects: 1240

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 1240

Group type: EXPERIMENTAL
Intervention: Integrated care intervention
Number of subjects: 1240
Study: 35136417

Group type: EXPERIMENTAL
Intervention: Manual reduction (treatment group)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study: 33964855

Group type: EXPERIMENTAL
Intervention: 10 µg vitamin D3/d
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: 20 µg vitamin D3/d
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Both treatment groups
Number of subjects: 240
Study: 32638614

Group type: EXPERIMENTAL
Intervention: High-Intensity Laser Therapy (HILT) plus routine physical therapy
Number of subjects: 50

Group type: COMPARATOR
Intervention: Sham HILT plus routine physical therapy
Number of subjects: 50
Study: 34716820

Group type: EXPERIMENTAL
Intervention: Swedish massage (SM)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Interferential electrical stimulation (IES)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 90
Study: 33972995

Group type: EXPERIMENTAL
Intervention: Efavirenz
Number of subjects: 8291
Study: 32434359

Group type: EXPERIMENTAL
Intervention: Manual 23G silicone oil removal method
Number of subjects: 130

Group type: COMPARATOR
Intervention: Vitrectomy system
Number of subjects: 130
Study: 34989171

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (800 IU/day) for 28 days
Number of subjects: 112

Group type: COMPARATOR
Intervention: Control group (no vitamin D supplementation)
Number of subjects: 112
Study: 34938826

Group type: EXPERIMENTAL
Intervention: 7-day 50% reduction in time spent on social media (Facebook, Instagram, Snapchat, YouTube)
Number of subjects: 76

Group type: COMPARATOR
Intervention: 10% reduction in time spent on social media (Control group)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Overall participant behavior
Number of subjects: 76
Study: 36067484

Group type: EXPERIMENTAL
Intervention: Polylactic acid membrane
Number of subjects: 60

Group type: COMPARATOR
Intervention: Polyurethane film
Number of subjects: 60
Study: 33048879

Group type: EXPERIMENTAL
Intervention: Doravirine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ritonavir‐boosted darunavir
Number of subjects: 0

Group type: COMPARATOR
Intervention: Efavirenz
Number of subjects: 0
Study: 34347950

Group type: EXPERIMENTAL
Intervention: REGEN-COV (1200 mg subcutaneous injection)
Number of subjects: 1505

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1505
Study: 33767311

Group type: EXPERIMENTAL
Intervention: Handheld fan (HHF) for symptom control
Number of subjects: 30

Group type: COMPARATOR
Intervention: No intervention (control)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Handheld fan (HHF)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Oxygen therapy
Number of subjects: 30
Study: 32568065

Group type: EXPERIMENTAL
Intervention: Oral sodium bicarbonate (starting at 500 mg three times daily, increasing to 1 g three times daily if serum bicarbonate < 22 mmol/l at 3 months)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 300
Study: 36126314

Group type: EXPERIMENTAL
Intervention: Kinect-based exergame program (n=11)
Number of subjects: 22
Study: 33009930

Group type: EXPERIMENTAL
Intervention: Platelet-rich fibrin (PRF)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 67
Study: 32997871

Group type: EXPERIMENTAL
Intervention: Cognitive Analytic Therapy (CAT) plus Treatment as Usual (TAU)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Cognitive Analytic Therapy (CAT)
Number of subjects: 39
Study: 36117580

Group type: EXPERIMENTAL
Intervention: Hypocaloric modified MIND diet
Number of subjects: 37

Group type: COMPARATOR
Intervention: Hypocaloric control diet
Number of subjects: 37
Study: 33522061

Group type: EXPERIMENTAL
Intervention: Parent-mediated micro-intervention with facilitated reaching using Velcro-affixed mittens and toys.
Number of subjects: 73

Group type: COMPARATOR
Intervention: Alternative treatment condition involving toy-based interactions with caregivers.
Number of subjects: 73
Study: 35999254

Group type: EXPERIMENTAL
Intervention: 2-minute walk test (2mWT)
Number of subjects: 50
Study: 33729984

Group type: EXPERIMENTAL
Intervention: Healing Hearts Together (HHT) intervention, an 8-week couples-based program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 35523485

Group type: EXPERIMENTAL
Intervention: Epicardial injection of hiPSC‐CMs (1×10^8, 2×10^8, and 4×10^8 cells) during CABG surgery
Number of subjects: 0

Group type: COMPARATOR
Intervention: CABG surgery alone
Number of subjects: 0
Study: 34247202

Group type: EXPERIMENTAL
Intervention: Allele score for BMI
Number of subjects: 5424

Group type: EXPERIMENTAL
Intervention: Allele score for worry
Number of subjects: 5424

Group type: EXPERIMENTAL
Intervention: BMI
Number of subjects: 5424
Study: 33426734

Group type: EXPERIMENTAL
Intervention: Lung ultrasound (LUS) scan interpretation by physicians
Number of subjects: 20
Study: 32471373

Group type: EXPERIMENTAL
Intervention: PMES plus antidepressant
Number of subjects: 258

Group type: COMPARATOR
Intervention: Sham plus antidepressant
Number of subjects: 258
Study: 35382961

Group type: EXPERIMENTAL
Intervention: Hydromorphone combined with ropivacaine (5 μg/kg hydromorphone + 0.2% ropivacaine)
Number of subjects: 120

Group type: COMPARATOR
Intervention: 0.2% ropivacaine
Number of subjects: 120
Study: 33781228

Group type: EXPERIMENTAL
Intervention: Prime Time Sister Circles (PTSC) program, a 13-week multifaceted peer support intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prime Time Sister Circles (PTSC) program
Number of subjects: 0
Study: 32312147

Group type: EXPERIMENTAL
Intervention: Nomogram for predicting overall survival
Number of subjects: 0
Study: 35353129

Group type: EXPERIMENTAL
Intervention: PIMSRA
Number of subjects: 200
Study: 32052316

Group type: EXPERIMENTAL
Intervention: Pulmonary cement embolism
Number of subjects: 121

Group type: COMPARATOR
Intervention: No pulmonary cement embolism (Control)
Number of subjects: 121
Study: 35130507

Group type: EXPERIMENTAL
Intervention: Jump training
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Complex training
Number of subjects: 16

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 16
Study: 33729148

Group type: EXPERIMENTAL
Intervention: Self-made protective clothing
Number of subjects: 86

Group type: COMPARATOR
Intervention: Standard protective clothing
Number of subjects: 86
Study: 35568897

Group type: COMPARATOR
Intervention: Full-body resistance training (FB)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Split-body resistance training (SPLIT)
Number of subjects: 50
Study: 35664492

Group type: EXPERIMENTAL
Intervention: Venlafaxine 150 mg daily
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 34457215

Group type: EXPERIMENTAL
Intervention: Quality management by objectives in patient care for persistent vacuum sealing drainage (VSD)
Number of subjects: 164

Group type: COMPARATOR
Intervention: Original nursing model
Number of subjects: 164
Study: 32339235

Group type: EXPERIMENTAL
Intervention: Hypofractionated radiation therapy (RT) with concurrent and adjuvant temozolomide (TMZ)
Number of subjects: 1321

Group type: EXPERIMENTAL
Intervention: Single modality treatment with temozolomide (TMZ)
Number of subjects: 1321

Group type: EXPERIMENTAL
Intervention: Shorter courses of RT
Number of subjects: 1321
Study: 35035214

Group type: EXPERIMENTAL
Intervention: Muscle fenestration
Number of subjects: 18

Group type: COMPARATOR
Intervention: Classic muscle recession
Number of subjects: 18
Study: 36044559

Group type: EXPERIMENTAL
Intervention: Empowerment intervention consisting of 7 sessions
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study: 35920662

Group type: EXPERIMENTAL
Intervention: Cefepime (2 g) and Taniborbactam (0.5 g) administered as a single intravenous infusion over 2 hours.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cefepime and Taniborbactam in subjects with mild, moderate, and severe renal impairment compared to normal renal function.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cefepime and Taniborbactam during hemodialysis.
Number of subjects: 0
Study: 32507103

Group type: EXPERIMENTAL
Intervention: GA-ANN method
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: GA-MLR method
Number of subjects: 43
Study: 36409962

Group type: EXPERIMENTAL
Intervention: Four Hmong word recognition lists
Number of subjects: 70

Group type: COMPARATOR
Intervention: English word list - List 1A of the Northwestern University Auditory Test No. 6
Number of subjects: 70
Study: 33276294

Group type: EXPERIMENTAL
Intervention: Non-sedation
Number of subjects: 205

Group type: COMPARATOR
Intervention: Sedation
Number of subjects: 205
Study: 32423930

Group type: EXPERIMENTAL
Intervention: XZK 1200 mg once per day (OD group)
Number of subjects: 316

Group type: COMPARATOR
Intervention: XZK 600 mg two times per day (TD group)
Number of subjects: 316
Study: 34215704

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (HCQ) 200-400 mg/day
Number of subjects: 153

Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (HCQ)
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (HCQ) and Placebo
Number of subjects: 153
Study: 34702123

Group type: EXPERIMENTAL
Intervention: Dapagliflozin plus standard treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard treatment alone
Number of subjects: 0
Study: 34279564

Group type: EXPERIMENTAL
Intervention: Daily coffee intake
Number of subjects: 386258

Group type: EXPERIMENTAL
Intervention: Mendelian randomization study using genetic variants
Number of subjects: 386258
Study: 32070302

Group type: EXPERIMENTAL
Intervention: mTAP (a mixture of metronidazole, ciprofloxacin, and cefaclor)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Ca(OH)2
Number of subjects: 45

Group type: COMPARATOR
Intervention: No intracanal medicament (Control)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: MTA
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: BC fast set putty
Number of subjects: 45
Study: 34010226

Group type: EXPERIMENTAL
Intervention: Cathodal transcranial direct current stimulation (10 sessions of 20 minutes over 2 weeks)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Cathodal transcranial direct current stimulation
Number of subjects: 20
Study: 35373083

Group type: EXPERIMENTAL
Intervention: FX CorAL 600
Number of subjects: 70

Group type: COMPARATOR
Intervention: SureFlux 17UX
Number of subjects: 70

Group type: COMPARATOR
Intervention: Polyflux 170H
Number of subjects: 70
Study: 33074913

Group type: EXPERIMENTAL
Intervention: Interactive web-based breastfeeding monitoring system
Number of subjects: 106

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 106
Study: 35195808

Group type: EXPERIMENTAL
Intervention: SAD vignette (experimental condition)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Non-SAD vignette (control condition)
Number of subjects: 103
Study: 34343032

Group type: EXPERIMENTAL
Intervention: Vincristine-Irinotecan-Temozolomide (VIT)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Vincristine-Irinotecan (VI)
Number of subjects: 120
Study: 35548882

Group type: EXPERIMENTAL
Intervention: Staff training
Number of subjects: 350

Group type: EXPERIMENTAL
Intervention: Student workshops
Number of subjects: 350

Group type: EXPERIMENTAL
Intervention: Both staff and student training
Number of subjects: 350

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 350
Study: 33220354

Group type: EXPERIMENTAL
Intervention: Anakinra plus methylprednisolone
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control (untreated historical controls)
Number of subjects: 120
Study: 33035457

Group type: EXPERIMENTAL
Intervention: Tazemetostat 800 mg orally twice per day in continuous 28-day cycles
Number of subjects: 99
Study: 32853747

Group type: EXPERIMENTAL
Intervention: Long-term albumin administration
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: On-treatment serum albumin levels
Number of subjects: 0

Group type: COMPARATOR
Intervention: Patients whose on-treatment serum albumin remained below normal
Number of subjects: 0
Study: 33462580

Group type: EXPERIMENTAL
Intervention: Ivermectin (400 µg/kg for 3 days)
Number of subjects: 203

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Ivermectin
Number of subjects: 203
Study: 32186237

Group type: EXPERIMENTAL
Intervention: Cupulolith repositioning maneuver (CuRM)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Therapeutic head‐shaking maneuver
Number of subjects: 49

Group type: COMPARATOR
Intervention: Modified Lempert maneuver
Number of subjects: 49
Study: 36037586

Group type: EXPERIMENTAL
Intervention: BUP/NX flexible model of care with flexible take-home dosing (n = 138)
Number of subjects: 272

Group type: COMPARATOR
Intervention: Standard model of care with closely supervised methadone (n = 134)
Number of subjects: 272

Group type: EXPERIMENTAL
Intervention: BUP/NX flexible model of care
Number of subjects: 272

Group type: COMPARATOR
Intervention: Standard model of care with closely supervised methadone
Number of subjects: 272
Study: 33960254

Group type: EXPERIMENTAL
Intervention: ECG-gated photographs
Number of subjects: 30